Neurointerventional Program

Stroke and Interventional Research Studies

MCW-Froedtert hospital is involved with cutting edge treatments for ischemic and hemorrhagic stroke. These studies include:

• Interventional Management of Stroke (IMS-III) study of combined IV and IA thrombolysis in acute ischemic stroke within three hours of symptoms onset versus IV only.
• Penumbra mechanical clot retrieval device for acute ischemic stroke within 8 hours of symptoms onset
• Wingspan intracranial stenting versus medical therapy in symptomatic intracranial stenosis (SAMMPRIS study)
• Neuroflow balloon in acute ischemic stroke
• Albumin in acute ischemic stroke therapy
• Neuroprotective in ischemic stroke therapy
• Micrus coil cerebral aneurysm registry
• A Randomized trial of Unruptured Brain AVMs (ARUBA) study
• Carotid stent registries
• Merci® clot retrieval device registry
• Ancrod study